Dr. Brent Norton is a bilingual business leader with a strong track record of building and governing successful healthcare organizations from start-up through commercialization. He uses cross-functional knowledge to develop strategy, raise capital, and build relationships across the academic and business communities, with contributions that have delivered significant returns for early investors and positively impacted hundreds of thousands of lives. Dr. Norton founded PreMD, completing an IPO and listings on the TSX and AMEX, built its R&D and commercial operations, led transactions with AstraZeneca, Eli Lilly, and L'Oréal, and took products through the FDA to global out-licensing with J&J. He was also a founding Director of Novadaq Technologies, which was sold to Stryker.

Dr. Norton holds an MD/CM from McGill University, an MBA from the University of Western Ontario's Richard Ivey School of Business, and is a certified director from the Institute of Corporate Directors. He currently serves on the Board of Directors and Executive Committee of the Association of the Faculties of Medicine of Canada (AFMC), where he chairs the Audit, Finance & Risk Committee, and is a member of the Arthritis Society Canada National Council and Innovation Committee. A active board member and volunteer in both Canada and the US, he has frequently worked with founders and CEOs through significant inflection points, including commercial validation, monetization of assets, and turnarounds of IP and regulatory-based companies.